Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis

Yu Xiaa School of Clinical Medical, Weifang Medical University, Weifang, China;b Department of Gynecology and Obstetrics, Beijing Jishuitan Hospital, Beijing, ChinaView further author information

He Wangc Department of Gynecology and Obstetrics, Weifang People’s Hospital, Weifang, ChinaView further author information

Jing Zhangb Department of Gynecology and Obstetrics, Beijing Jishuitan Hospital, Beijing, ChinaView further author information

Yongjun Wangb Department of Gynecology and Obstetrics, Beijing Jishuitan Hospital, Beijing, ChinaCorrespondence[email protected]

https://orcid.org/0000-0003-4877-2694 View further author information

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date